主页 文献库文献详情
PMID: 42677692 已发表 · ppublish 英语

Pregnancy after breast cancer: obstetrics and feto-maternal outcomes.

European review for medical and pharmacological sciences ·第 30 卷 ·第 8 期 ·2026-08-00

Fabiani C, Sanna F, Guarino A, Sperduti I, D'Auria G, Corrado G, Cocchiaro T, Meneghini C, Licata E, Paciotti G, Spina V, Corno R, Loggia M, Rucci C, Rago A, Rago R

摘要

Pregnancy after breast cancer (BC) is possible and does not have a negative impact on prognosis, even in hormone receptor-positive or BRCA1/2-mutated patients. Despite this, the estimated pregnancy achievability in BC survivors is significantly inferior when compared to that of women who did not have cancer. This study investigated pregnancies after BC in 18 women monitored at the Oncofertility Center of the Italian Sandro Pertini Hospital. We compared maternal, fetal, and neonatal outcomes against general population data. Then, we evaluated the impact of chemotherapy on feto-maternal outcomes. Compared to findings from the general population, our results show that pregnancy after BC may have more obstetrical complications, such as premature delivery and cesarean section; in addition, our research showed a possible correlation between the occurrence of gestational diabetes and previous chemotherapy treatment. The rate of breastfed survivors appeared lower than that of women in the general population, as summarized in the article's main findings. Based on our data, pregnancy after BC is safe for both mother and fetus/newborn but requires strict follow-up in referral centers to best manage possible obstetric complications, particularly in women who have undergone chemotherapy.

文献信息
期刊
European review for medical and pharmacological sciences
期刊简称
Eur Rev Med Pharmacol Sci
ISSN
2284-0729
发表日期
2026-08-00
语言
英语
国家/地区
United States
NLM ID
9717360
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com